Molecular imaging has the potential to have a significant impact on different phases of drug development ... and characterization of disease, and evaluation of treatment 6. The advantage of ...

Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the ...

The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

The Phase 3 portion of the trial has ... image-guided surgical drugs. Its late-stage drug for ureter imaging is currently under evaluation in a pivotal trial. For more information, visit ...